|
Re: Completion of Affinity 1 - Patients Enrolled Listed as 518, Required 471
|
3
|
Mannkind
|
May 31, 2013 05:49PM
|
|
Re: Companies That Are Fighting The Insulin Battle
|
|
Mannkind
|
Jun 13, 2012 09:13PM
|
|
Re: Commit To Buy MannKind Corp At $2.50, Earn 28%
|
|
Mannkind
|
May 23, 2013 05:39PM
|
|
Re: Colby Agreement
|
2
|
Mannkind
|
Nov 13, 2012 11:16AM
|
|
Re: Colby Agreement
|
1
|
Mannkind
|
Nov 13, 2012 11:47AM
|
|
Re: Colby Agreement
|
|
Mannkind
|
Nov 13, 2012 09:44AM
|
|
Re: CC transcript
|
|
Mannkind
|
Aug 14, 2013 09:13PM
|
|
Re: CC Notes / Financing and Partnership Discussion
|
|
Mannkind
|
Feb 14, 2013 10:01AM
|
|
Re: CC Notes / Financing and Partnership Discussion
|
1
|
Mannkind
|
Mar 19, 2013 07:33AM
|
|
Re: CC Notes
|
|
Mannkind
|
Feb 11, 2013 08:33PM
|
|
Re: Can some one refresh memory why MNKD's first FDA drug application was denied
|
|
Mannkind
|
Mar 22, 2013 09:19AM
|
|
Re: Can some one refresh memory why MNKD's first FDA drug application was denied
|
1
|
Mannkind
|
Mar 22, 2013 09:35AM
|
|
Re: Buyouts & MNKD Partnerships
|
1
|
Mannkind
|
Mar 28, 2012 12:34PM
|
|
Re: Buy, Sell, or Hold: MannKind
|
|
Mannkind
|
Sep 17, 2012 09:44AM
|
|
Re: Btk Inhibitors — Pointing the Way to the Future of Targeted Therapies?
|
|
Mannkind
|
May 08, 2012 10:47PM
|
|
Re: Btk Inhibitors — Pointing the Way to the Future of Targeted Therapies?
|
|
Mannkind
|
May 09, 2012 09:25AM
|
|
Re: Bristol Myers Squibb (BMY) Nabs Diabetes Player Amylin Pharmaceuticals (AMLN). W
|
|
Mannkind
|
Jul 02, 2012 02:51PM
|
|
Re: Bristol Myers Squibb (BMY) Nabs Diabetes Player Amylin Pharmaceuticals (AMLN). W
|
|
Mannkind
|
Jul 02, 2012 02:57PM
|
|
Re: Brinson Patrick initiates coverage on MannKind Corp...
|
|
Mannkind
|
Dec 03, 2012 12:46PM
|
|
Re: brentie98
|
|
Mannkind
|
Aug 12, 2012 10:21AM
|
